ES8701158A1 - Procedimiento para la obtencion de compuestos carbonilicos - Google Patents

Procedimiento para la obtencion de compuestos carbonilicos

Info

Publication number
ES8701158A1
ES8701158A1 ES546945A ES546945A ES8701158A1 ES 8701158 A1 ES8701158 A1 ES 8701158A1 ES 546945 A ES546945 A ES 546945A ES 546945 A ES546945 A ES 546945A ES 8701158 A1 ES8701158 A1 ES 8701158A1
Authority
ES
Spain
Prior art keywords
group
lower alkyl
represents lower
carbon atoms
alk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES546945A
Other languages
English (en)
Other versions
ES546945A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES546945A0 publication Critical patent/ES546945A0/es
Publication of ES8701158A1 publication Critical patent/ES8701158A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Procedimiento para la obtención de compuestos carbonílicos de fórmula **(Ver fórmula)** donde R significa un resto arilo carbocíclico o heterocíclico, R1 significa alquilo inferior, uno de los grupos R2 y R3 significa alquilo inferior y el otro significa alquilo inferior, ciano o amino, X significa oxígeno o el grupo -NH-, y alk significa alquileno inferior que separa el grupo X del átomo de nitrógeno del anillo por como mínimo dos átomos de carbono, Y significa los grupos -CHOH- o -(C=O)- y Ar1 representa un resto arilo o heteroarilo monocíclico donde, en caso de que R1, R2 y R3 en cada caso sea alquilo inferior, X significa oxígeno, alk significa alquileno de cadena recta con 2 hasta 4 átomos de carbono, Y es el grupo -(C=O)-, y R tiene el significado indicado, Ar1 es distinto de fenilo insustituido, así como las sales de tales compuestos.
ES546945A 1984-09-14 1985-09-13 Procedimiento para la obtencion de compuestos carbonilicos Expired ES8701158A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH438884 1984-09-14

Publications (2)

Publication Number Publication Date
ES546945A0 ES546945A0 (es) 1986-11-16
ES8701158A1 true ES8701158A1 (es) 1986-11-16

Family

ID=4275188

Family Applications (4)

Application Number Title Priority Date Filing Date
ES546946A Expired ES8802025A1 (es) 1984-09-14 1985-09-13 Procedimiento para la obtencion de compuestos de fenilalqui-lo
ES546945A Expired ES8701158A1 (es) 1984-09-14 1985-09-13 Procedimiento para la obtencion de compuestos carbonilicos
ES554487A Expired ES8706669A1 (es) 1984-09-14 1986-04-29 Procedimiento para la obtencion de compuestos carbonilicos
ES554488A Expired ES8800926A1 (es) 1984-09-14 1986-04-29 Procedimiento para la obtencion de compuestos carbonilicos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES546946A Expired ES8802025A1 (es) 1984-09-14 1985-09-13 Procedimiento para la obtencion de compuestos de fenilalqui-lo

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES554487A Expired ES8706669A1 (es) 1984-09-14 1986-04-29 Procedimiento para la obtencion de compuestos carbonilicos
ES554488A Expired ES8800926A1 (es) 1984-09-14 1986-04-29 Procedimiento para la obtencion de compuestos carbonilicos

Country Status (16)

Country Link
US (1) US4853393A (es)
EP (2) EP0174654A3 (es)
JP (2) JPS6172751A (es)
KR (1) KR890000225B1 (es)
AU (1) AU4744985A (es)
DD (1) DD237165A5 (es)
DK (2) DK416985A (es)
ES (4) ES8802025A1 (es)
FI (2) FI853477L (es)
GR (2) GR852216B (es)
HU (1) HU194871B (es)
IL (1) IL76366A (es)
NO (1) NO853609L (es)
NZ (1) NZ213461A (es)
PT (2) PT81116B (es)
ZA (1) ZA857034B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK159420C (da) * 1983-03-09 1991-03-11 Ciba Geigy Ag N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater
FI853477L (fi) * 1984-09-14 1986-03-15 Ciba Geigy Ag Foerfarande foer framstaellning av karbonylfoereningar.
JPS61227567A (ja) * 1985-04-01 1986-10-09 Eisai Co Ltd １，４−ジヒドロピリジン誘導体
DE3682857D1 (en) * 1985-09-13 1992-01-23 Green Cross Corp Dihydropyridinderivate.
EP0222702A3 (de) * 1985-11-06 1988-01-07 Ciba-Geigy Ag Basische Carbonylverbindungen
DE3601397A1 (de) * 1986-01-18 1987-07-23 Bayer Ag Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4994461A (en) * 1987-03-27 1991-02-19 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine enantiomers
WO1988007531A1 (en) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh New optically active compounds
DE3724909A1 (de) * 1987-07-28 1989-02-09 Bayer Ag Neue substituierte nitro-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
US5100892A (en) * 1990-11-13 1992-03-31 Glaxo Inc. Dihydropyridine vasodilator agents
US5258519A (en) * 1990-11-13 1993-11-02 Glaxo Inc. Dihydropyridine vasodilators agents
US5767131A (en) * 1993-04-05 1998-06-16 Synaptic Pharmaceutical Corporation Dihydropyridines and new uses thereof
US6211198B1 (en) 1993-04-05 2001-04-03 Synaptic Pharmaceutical Corporation Dihydropyridines and new uses thereof
CA2361366A1 (en) 1999-03-26 2000-10-05 Nicholas Kindon Novel compounds
AU4688301A (en) * 2000-04-11 2001-10-23 Sankyo Co Stabilized pharmaceutical compositions containing calcium channel blockers
GB0013060D0 (en) * 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
GB0021670D0 (en) * 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
GB0117899D0 (en) * 2001-07-23 2001-09-12 Astrazeneca Ab Chemical compounds
SE0102809D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab Novel compounds
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
JPS5283672A (en) * 1976-01-01 1977-07-12 Yamanouchi Pharmaceut Co Ltd Novel 2-amino-1,4-dihydropyridine derivatives
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
WO1983003249A1 (en) * 1982-03-17 1983-09-29 Yoshitomi Pharmaceutical 1,4-dihydropyridine-3,5-dicarboxylate derivatives
EP0094159B1 (en) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dihydropyridine derivatives, their production and use
WO1983004023A1 (en) * 1982-05-10 1983-11-24 Takeda Chemical Industries, Ltd. Dihydropyridine derivatives
JPS58201765A (ja) * 1982-05-10 1983-11-24 Takeda Chem Ind Ltd ジヒドロピリジン誘導体，その製造法および用途
WO1984002702A1 (en) * 1983-01-11 1984-07-19 Takeda Chemical Industries Ltd Dihydropyridine derivatives
IT1198377B (it) * 1982-06-03 1988-12-21 Pierrel Spa Esteri basici ad attivita' calcioanatagonista,procedimenti per la loro preparazione e relative composizioni farmaceutiche
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
EP0111455A3 (de) * 1982-12-10 1984-07-25 Ciba-Geigy Ag Ungesättigte Lactone
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
FI853477L (fi) * 1984-09-14 1986-03-15 Ciba Geigy Ag Foerfarande foer framstaellning av karbonylfoereningar.

Also Published As

Publication number Publication date
ES546946A0 (es) 1987-02-16
DK416985D0 (da) 1985-09-13
JPS6172752A (ja) 1986-04-14
FI853478A0 (fi) 1985-09-11
ES8800926A1 (es) 1987-12-01
IL76366A (en) 1989-07-31
DK416885D0 (da) 1985-09-13
AU4744985A (en) 1986-03-20
ES546945A0 (es) 1986-11-16
US4853393A (en) 1989-08-01
ES554487A0 (es) 1987-07-01
KR890000225B1 (ko) 1989-03-11
FI853478L (fi) 1986-03-15
DK416985A (da) 1986-03-15
IL76366A0 (en) 1986-01-31
KR860002496A (ko) 1986-04-26
DK416885A (da) 1986-03-15
ES8802025A1 (es) 1987-02-16
PT81116A (en) 1985-10-01
GR852215B (es) 1986-01-14
EP0174654A3 (de) 1987-07-22
NO853609L (no) 1986-03-17
NZ213461A (en) 1989-07-27
ES554488A0 (es) 1987-12-01
PT81116B (en) 1987-07-15
PT81117B (en) 1987-07-15
FI853477A0 (fi) 1985-09-11
EP0174653A3 (de) 1987-06-16
ZA857034B (en) 1987-05-27
HU194871B (en) 1988-03-28
FI853477L (fi) 1986-03-15
DD237165A5 (de) 1986-07-02
PT81117A (en) 1985-10-01
ES8706669A1 (es) 1987-07-01
JPS6172751A (ja) 1986-04-14
EP0174653A2 (de) 1986-03-19
GR852216B (es) 1986-01-14
HUT38339A (en) 1986-05-28
EP0174654A2 (de) 1986-03-19

Similar Documents

Publication Publication Date Title
ES8701158A1 (es) Procedimiento para la obtencion de compuestos carbonilicos
ATE20469T1 (de) Carboxyalkyl-dipeptide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
IE812460L (en) Substituted azabicyclo-octane-carboxylic acids
ES2000481A6 (es) Procecimiento de preparacion de nuevos derivados del dihidro-2,3 benzofurano
EP0209127A3 (en) Poly(2,2,6,6-tetramethyl-piperidyl-amino)-1,3,5-triazines as stabilizers for synthetic polymer compositions
GB8627059D0 (en) Substituted trialine derivatives
ES8707525A1 (es) Un procedimiento para la preparacion de nuevas isoindolinil-alquilpiperazinas
ATE108194T1 (de) Stabilisierte copolymerzusammensetzungen.
AU6658486A (en) New anthracyclines and drugs containing them
ES2000865A6 (es) Procedimiento para la obtencion de derivados del acido 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilico
EP0204148A3 (en) [1,4]Benzodioxin and [1,4]benzoxazine derivatives
ES8603414A1 (es) Un procedimiento para preparar un derivado de 1, 4-dihidropiridina disustituido en posicion 2, 6
DE3578064D1 (de) Aminobenzamide derivate.
ES2006336A6 (es) Procedimiento de preparacion de nuevas acetamidas derivadas de la 2,3-dihidro-3-fenil-2-benzofuranona.
ES8607939A1 (es) Procedimiento de preparacion de nuevos derivados de la 8-al-coxicarbonilaminoisoquinolina y de sus sales de adicion aci-da